Interview: Hemogenyx

This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

[youtube https://www.youtube.com/watch?v=6kG7G_Hwo9U&w=560&h=315]
Zak Mir

Zak Mir

About Me

Zak Mir is a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator. Zak presents the daily Bulletin Board Heroes which can be seen here at Share Talk

Recent Posts

Zak Mir Twitter

RT @Share_Talk: ⏫#BulletinBoardHeroes 6⃣ 52-wk high #AAA #CHAR #DDDD #JLP #PPIX #PRE 🔝@ZaksTradersCafe 👏👏👏 🍷... Read More

Sep 15 2020, 7:00 pm

RT @Share_Talk: Daily Review #BulletinBoardHeroes Tuesday,15th Sep 2020 @ZaksTradersCafe 🎓 #88E+29.73% #AAA+4.39%🔝#BIDS+21.29% #CHAR+10.73… Read More

Sep 15 2020, 6:52 pm

RT @Share_Talk: Colin Bird, Executive Chairman @GalileoResource (#GLR.L) Podcast 🎧 Share Purchase Agreement re Acquisition... Read More

Sep 15 2020, 2:54 pm

Bulliten Board Heroes